Skip to main content
. Author manuscript; available in PMC: 2014 Sep 25.
Published in final edited form as: Eur Urol. 2010 Jul 9;58(4):574–580. doi: 10.1016/j.eururo.2010.07.003

Table 1.

Descriptive preoperative characteristics of 253 patients treated with radical nephroureterectomy and ipsilateral bladder cuff for upper-tract urothelial carcinoma

Variable All patients
(n = 253)
Tumor location*
Renal pelvis (n =
171)
Ureter (n =
78)
p value
Median age, yr (IQR) 72
(64-77)
71 (63-78) 73 (66-77) 0.7
Gender, No. (%)
 Male 159 (63) 104 (61) 52 (67) 0.4
 Female 94 (37) 67 (39) 26 (33) -
Race, No. (%)
 White 233 (92) 157 (92) 72 (92) 0.8
 Other 20 (8) 14 (8) 6 (8) -
ASA score, No. (%)
 1 7 (3) 4 (2) 3 (4) 0.8
 2 126 (50) 86 (50) 39 (50) -
 3 119 (47) 80 (47) 36 (46) -
Smoking history, No. (%) 186 (74) 128 (75) 54 (69) 0.4
Previous non-muscle-invasive
bladder tumor, No. (%)
86 (34) 52 (30) 31 (40) 0.2
Previous endoscopic tumor ablation,
No. (%)
20 (8) 10 (6) 6 (8) 0.6
Hematuria, No. (%)
 No 63 (25) 36 (21) 27 (35) 0.04
 Microhematuria 28 (11) 22 (13) 5 (6) -
 Gross hematuria 162 (64) 113 (66) 46 (59) -
Positive void cytology, No. (%) 191 (75) 126 (74) 64 (82) 0.3
Hydronephrosis on preoperative
imaging, No. (%)
125 (49) 62 (36) 62 (79) <0.000
1
Parenchymal/sinus fat extension or
extraureter extension on imaging, No.
(%)
26 (10) 30 (18) 6 (8) 0.05
Suspicious nodes on imaging, No. (%) 21 (8) 16 (9) 5 (6) 0.6
High-grade disease, No. (%) 181 (73) 121 (71) 58 (74) 0.6

IQR = interquartile range; ASA = American Society of Anesthesiologists.

*

n = 4, pT0 patients (submitted to previous endoscopic tumor ablation).

Based on biopsy and wash/brush cytology.